| Emergence of genomic diversity and recurrent mutations in SARS-CoV-2 L Van Dorp, M Acman, D Richard, LP Shaw, CE Ford, L Ormond, ... Infection, Genetics and Evolution 83, 104351, 2020 | 898 | 2020 |
| Favipiravir at high doses has potent antiviral activity in SARS-CoV-2− infected hamsters, whereas hydroxychloroquine lacks activity SJF Kaptein, S Jacobs, L Langendries, L Seldeslachts, S Ter Horst, ... Proceedings of the National Academy of Sciences 117 (43), 26955-26965, 2020 | 279 | 2020 |
| The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model R Abdelnabi, CS Foo, SJF Kaptein, X Zhang, TND Do, L Langendries, ... EBioMedicine 72, 2021 | 134* | 2021 |
| SARS-CoV-2 polymorphisms and multisystem inflammatory syndrome in children J Pang, FAT Boshier, N Alders, G Dixon, J Breuer Pediatrics 146 (6), 2020 | 33 | 2020 |
| Systematic review and patient‐level meta‐analysis of SARS‐CoV‐2 viral dynamics to model response to antiviral therapies S Gastine, J Pang, FAT Boshier, SJ Carter, DO Lonsdale, M Cortina‐Borja, ... Clinical Pharmacology & Therapeutics 110 (2), 321-333, 2021 | 28 | 2021 |
| Evolution of viral variants in remdesivir‐treated and untreated SARS‐CoV‐2‐infected pediatrics patients FAT Boshier, J Pang, J Penner, M Parker, N Alders, A Bamford, ... Journal of medical virology 94 (1), 161-172, 2022 | 25* | 2022 |
| Mixed cytomegalovirus genotypes in HIV-positive mothers show compartmentalization and distinct patterns of transmission to infants J Pang, JA Slyker, S Roy, J Bryant, C Atkinson, J Cudini, C Farquhar, ... Elife 9, e63199, 2020 | 21 | 2020 |
| Haplotype assignment of longitudinal viral deep sequencing data using covariation of variant frequencies C Venturini, J Pang, AU Tamuri, S Roy, C Atkinson, P Griffiths, J Breuer, ... Virus Evolution 8 (2), veac093, 2022 | 19 | 2022 |
| Reliability of Spike Gene Target Failure for ascertaining SARS-CoV-2 lineage B. 1.1. 7 prevalence in a hospital setting JA Guerra-Assunção, PA Randell, FAT Boshier, MA Crone, J Pang, ... MedRxiv, 2021.04. 12.21255084, 2021 | 9 | 2021 |
| Detection of a reservoir of bedaquiline/clofazimine resistance associated variants in Mycobacterium tuberculosis predating the antibiotic era L Van Dorp, C Nimmo, AT Ortiz, J Pang, M Acman, C Tan, J Millard, ... bioRxiv, 2023 | 6* | 2023 |
| Favipiravir induces HuNoV viral mutagenesis and infectivity loss with clinical improvement in immunocompromised patients AY Kreins, E Roux, J Pang, I Cheng, O Charles, S Roy, R Mohammed, ... Clinical Immunology 259, 109901, 2024 | 2 | 2024 |
| Genetic consequences of effective and suboptimal dosing with mutagenic drugs in a hamster model of SARS-CoV-2 infection (preprint) C Illingworth, JA Guerra-Assuncao, S Gregg, OJ Charles, J Pang, S Roy, ... | 2* | 2023 |
| Detection of a historic reservoir of bedaquiline/clofazimine resistance-associated variants in Mycobacterium tuberculosis C Nimmo, AT Ortiz, CCS Tan, J Pang, M Acman, J Millard, N Padayatchi, ... Genome Medicine 16 (1), 34, 2024 | 1 | 2024 |
| Remdesivir induced viral RNA and subgenomic RNA suppression, and evolution of viral variants in SARS-CoV-2 infected patients.(preprint) FAT Boshier, J Pang, J Penner, J Hughes, M Parker, JG Shepherd, ... | 1 | 2020 |
| Treatment of a chronic human norovirus infection of an immunocompromised patient with favipiravir and nitazoxanide: assessing drug efficacy and the mechanism of action using a … E Roux, J Pang, A Kreins, J Standing, J Rymenants, J Neyts, J Breuer, ... International conference on antiviral research (ICAR), Date: 2022/03/21-2022 …, 2022 | | 2022 |
| Efficacy and mechanism of action of favipiravir and nitazoxanide in the treatment of a chronic norovirus infection in a severely immunocompromised patient E Roux, J Pang, A Kreins, J Standing, J Rymenants, J Neyts, J Breuer, ... The Belgian Society for Virology, Location: Online, 2021 | | 2021 |
| Case Report: severe paediatric COVID-19 pneumonitis treated with remdesivir and nitazoxanide N Sanchez Clemente, J Pang, C Rodrigues, P Aurora, J Breuer Wellcome Open Research 6, 329, 2021 | | 2021 |
